These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 26311412)

  • 1. Retinoid roles in blocking hepatocellular carcinoma.
    Shirakami Y; Sakai H; Shimizu M
    Hepatobiliary Surg Nutr; 2015 Aug; 4(4):222-8. PubMed ID: 26311412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmaceutical and nutraceutical approaches for preventing liver carcinogenesis: chemoprevention of hepatocellular carcinoma using acyclic retinoid and branched-chain amino acids.
    Shimizu M; Shirakami Y; Hanai T; Imai K; Suetsugu A; Takai K; Shiraki M; Moriwaki H
    Mol Nutr Food Res; 2014 Jan; 58(1):124-35. PubMed ID: 24273224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acyclic retinoid in chemoprevention of hepatocellular carcinoma: Targeting phosphorylated retinoid X receptor-α for prevention of liver carcinogenesis.
    Shimizu M; Shirakami Y; Imai K; Takai K; Moriwaki H
    J Carcinog; 2012; 11():11. PubMed ID: 23230390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategy and mechanism for the prevention of hepatocellular carcinoma: phosphorylated retinoid X receptor alpha is a critical target for hepatocellular carcinoma chemoprevention.
    Shimizu M; Takai K; Moriwaki H
    Cancer Sci; 2009 Mar; 100(3):369-74. PubMed ID: 19068086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acyclic retinoid in the chemoprevention of hepatocellular carcinoma (review).
    Kojima S; Okuno M; Matsushima-Nishiwaki R; Friedman SL; Moriwaki H
    Int J Oncol; 2004 Apr; 24(4):797-805. PubMed ID: 15010815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of acyclic retinoid in the chemoprevention of hepatocellular carcinoma: basic aspects, clinical applications, and future prospects.
    Shimizu M; Imai K; Takai K; Moriwaki H
    Curr Cancer Drug Targets; 2012 Nov; 12(9):1119-28. PubMed ID: 22873214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemoprevention of hepatocellular carcinoma by acyclic retinoid.
    Shimizu M; Sakai H; Moriwaki H
    Front Biosci (Landmark Ed); 2011 Jan; 16(2):759-69. PubMed ID: 21196201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic growth inhibition by acyclic retinoid and vitamin K2 in human hepatocellular carcinoma cells.
    Kanamori T; Shimizu M; Okuno M; Matsushima-Nishiwaki R; Tsurumi H; Kojima S; Moriwaki H
    Cancer Sci; 2007 Mar; 98(3):431-7. PubMed ID: 17270033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic growth inhibition of human hepatocellular carcinoma cells by acyclic retinoid and GW4064, a farnesoid X receptor ligand.
    Ohno T; Shirakami Y; Shimizu M; Kubota M; Sakai H; Yasuda Y; Kochi T; Tsurumi H; Moriwaki H
    Cancer Lett; 2012 Oct; 323(2):215-22. PubMed ID: 22579649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acyclic retinoid and angiotensin-II receptor blocker exert a combined protective effect against diethylnitrosamine-induced hepatocarcinogenesis in diabetic OLETF rats.
    Nishimura N; Kaji K; Kitade M; Aihara Y; Sato S; Seki K; Sawada Y; Takaya H; Okura Y; Kawaratani H; Moriya K; Namisaki T; Mitoro A; Yoshiji H
    BMC Cancer; 2018 Nov; 18(1):1164. PubMed ID: 30477453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinoids in cancer chemoprevention.
    Okuno M; Kojima S; Matsushima-Nishiwaki R; Tsurumi H; Muto Y; Friedman SL; Moriwaki H
    Curr Cancer Drug Targets; 2004 May; 4(3):285-98. PubMed ID: 15134535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevention of recurrent hepatocellular carcinoma with retinoid].
    Moriwaki H
    Gan To Kagaku Ryoho; 2001 Dec; 28(13):1980-4. PubMed ID: 11791378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peretinoin, an Acyclic Retinoid, for the Secondary Prevention of Hepatocellular Carcinoma.
    Woo HY; Yoo SY; Heo J
    Molecules; 2021 Jan; 26(2):. PubMed ID: 33435572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of hepatocellular carcinoma by targeting MYCN-positive liver cancer stem cells with acyclic retinoid.
    Qin XY; Suzuki H; Honda M; Okada H; Kaneko S; Inoue I; Ebisui E; Hashimoto K; Carninci P; Kanki K; Tatsukawa H; Ishibashi N; Masaki T; Matsuura T; Kagechika H; Toriguchi K; Hatano E; Shirakami Y; Shiota G; Shimizu M; Moriwaki H; Kojima S
    Proc Natl Acad Sci U S A; 2018 May; 115(19):4969-4974. PubMed ID: 29686061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of acyclic retinoid with branched-chain amino acids inhibits xenograft growth of human hepatoma cells in nude mice.
    Shimizu M; Shirakami Y; Sakai H; Iwasa J; Shiraki M; Takai K; Naiki T; Moriwaki H
    Hepatol Res; 2012 Dec; 42(12):1241-7. PubMed ID: 23181540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peretinoin, an acyclic retinoid, suppresses steatohepatitis and tumorigenesis by activating autophagy in mice fed an atherogenic high-fat diet.
    Okada H; Takabatake R; Honda M; Takegoshi K; Yamashita T; Nakamura M; Shirasaki T; Sakai Y; Shimakami T; Nagata N; Takamura T; Tanaka T; Kaneko S
    Oncotarget; 2017 Jun; 8(25):39978-39993. PubMed ID: 28591717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptosis induction by acyclic retinoid: a molecular basis of 'clonal deletion' therapy for hepatocellular carcinoma.
    Okuno M; Sano T; Matsushima-Nishiwaki R; Adachi S; Akita K; Okano Y; Kojima S; Moriwaki H
    Jpn J Clin Oncol; 2001 Aug; 31(8):359-62. PubMed ID: 11574627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinoids and their target genes in liver functions and diseases.
    Shiota G; Kanki K
    J Gastroenterol Hepatol; 2013 Aug; 28 Suppl 1():33-7. PubMed ID: 23855293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acyclic retinoid inhibits human hepatoma cell growth by suppressing fibroblast growth factor-mediated signaling pathways.
    Shao RX; Otsuka M; Kato N; Taniguchi H; Hoshida Y; Moriyama M; Kawabe T; Omata M
    Gastroenterology; 2005 Jan; 128(1):86-95. PubMed ID: 15633126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acyclic retinoid inhibits diethylnitrosamine-induced liver tumorigenesis in obese and diabetic C57BLKS/J- +(db)/+Lepr(db) mice.
    Shimizu M; Sakai H; Shirakami Y; Iwasa J; Yasuda Y; Kubota M; Takai K; Tsurumi H; Tanaka T; Moriwaki H
    Cancer Prev Res (Phila); 2011 Jan; 4(1):128-36. PubMed ID: 21071580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.